key: cord-1021188-ze6r6tww authors: Perchiazzi, Gaetano; Pellegrini, Mariangela; Chiodaroli, Elena; Urits, Ivan; Kaye, Alan D.; Viswanath, Omar; Varrassi, Giustino; Puntillo, Filomena title: The use of Positive End Expiratory Pressure in patients affected by COVID-19: time to reconsider the relation between morphology and physiology date: 2020-07-18 journal: Best Pract Res Clin Anaesthesiol DOI: 10.1016/j.bpa.2020.07.007 sha: fce872f2b7fda24b614239805ef6c082b0398155 doc_id: 1021188 cord_uid: ze6r6tww COVID-19 is a new disease with different phases that can be catastrophic for subpopulations of patients with cardiovascular and pulmonary disease states at baseline. Appreciation for these different phases and treatment modalities including manipulation of ventilatory settings and therapeutics has made if a less lethal disease than when it emerged earlier this year. Different aspects of the disease are still largely unknown. However, laboratory investigation and clinical course of the COVID-19 show that this new disease is not a typical ARDS process, especially during the first phase. For this reason, the best strategy to be applied is to treat differently the single phases and to support the single functions of the failing organs as they appear. The recent outbreak of the respiratory illness caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 1 has raised clinical and organizational concerns that culminated in the declaration of a pandemic on March 11 th , 2020 2 . The World Health Organization has named the disease caused by the SARS-CoV-2 as COVID-19, short for coronavirus disease 2019 3 . Covid-19 is a new disease and only a part of the mechanisms that subtend its clinical course have been elucidated. The progression from the nasopharyngeal cavity to the lung alveoli is suspected to be at the base of the onset of the most severe form of the disease; however, quantification of the minimum viral load that allows the onset of the disease is not known. The mechanisms of viral infection are better characterized 4 and replication also because the scientists have profited from previous knowledge on similar viruses. The passage from the cytopatic level to the alteration of tissue structure is again less understood, although is widely acknowledged that a key role is played by local and general immunologic mechanisms 5 . However, also here the balance between innate and adaptive immune system during the course of the disease is a subject of discussion 6 . For the reasons previously listed, in absence of certainties about several important steps of the pathophysiology, research has proceeded by gathering information about patterns of presentation by the observation of affected patients and then started ordering them in a possible time sequence of events. Using this method, a recent systematic review 7 on 42 published articles revealed that three clinical stages can be identified: viral infection, pulmonary involvement with inflammation, and fibrosis. In all the stages co-existed epithelial damage (inflammation and diffuse alveolar damage), microvascular damage (including thrombosis) and fibrinous pneumonia; the presence of fibrotic patterns appeared after 3 weeks from the onset of the disease. An important message from the mentioned paper by Polak and coworkers 7 is that "the patients can present with more than one pattern, either simultaneously or consecutively". As we can note later, this pathologic finding has important implications on the way we ventilate these patients. Parallel to this histopathological investigation, since the beginning of the COVID-19 outbreak, intensivists have tried to associate lung morphology (studied by computed tomography) with the measurements of lung mechanics on these patients. In a widely diffused editorial 8 , Gattinoni and coworkers on the base of the first evidences, outlined the presence of two different paradigmatic patterns, labeled as "phenotypes" by the authors. Among the first they reported that the disease was characterized by a severe hypoxemia often associated with a near normal respiratory system compliance, whose clinical expression was very inhomogeneous, ranging from normal breathing ("silent" hypoxemia) or to remarkable dyspnea 8 . The observation of many cases of the disease made them able to sketch two different patterns labeled as phenotype L and phenotype H. The characteristics of Type L were Low values of: Elastance, Low ventilation/perfusion ratio, Low lung weight and Low recruitability. Radiological expression of type L is a pattern based on multiple ground-glass /crazy paving opacities mainly in the subpleural region. Instead, the characteristics of Type H were High levels of: Elastance, Right-to-left shunt, lung weight and recruitability 8 . Radiologically, this last phenotype resembles a classical patchy ARDS pattern. The authors speculated that the clinical presentation of phase L was determined by an important hypoxemia deriving from a vasoplegic mechanism. In fact a preliminary hypothesis made them ascribe this phenomenon to the loss of the hypoxic pulmonary vasoconstriction reflex, which is physiologically able to divert the blood flow away from the poorly ventilated areas; the absence of this reflex would cause a remarkable hyperperfusion of gasless tissue 9 . The mechanism beyond hypoxia during L-phase could be the virus blockade of the ACE-2 vascular receptors 10 or a more complex epithelial-endothelial crosstalk, responsible of the endothelial disfunction and of a 'proinflammatory'/'procoagulant' phenotype change in the endothelial cells 11 . In the attempt of compensating for the hypoxemia, the patient progressively begins hyperventilate up to 15-20 ml/kg 8 , although in many cases, for the almost normal compliance, these patients do not complain about the presence of dyspnea. The tachypnea could be also caused by the viral neurotropism 12 , direct affecting the respiratory centers. In this model proposed by Gattinoni 8 in March, the transition to phase H can be caused by two possible mechanisms. If the patient is still breathing spontaneously, a combination of deep negative intrathoracic pressure and increased lung permeability (due to inflammation) brings to a P-SILI (=Patient-Self Induced Lung Injury) 13 . If the patients is already mechanically ventilated the reason of worsening can be a Ventilator-induced lung injury (VILI) 14 determined by a pattern of ventilation that is no more appropriate for the by now edematous lungs, characterized by a higher lung weight than normal, which through a high superimposed pressure creates dependent atelectasis and reduction of the space available for ventilation ("baby lung") 15 . The H-phase shares similar features with ARDS; for this reason, as in ARDS, the further stage in the evolution of COVID-19 can be characterized by a fibrotic evolution 16 .Two recurring component of the disease are trombofilia [17] [18] [19] and altered immune response 20 . The tendency to thrombophilia is associated to poor prognosis 21 . The progressive accumulation of clinical and radiological evidence, although maintaining intact the value of the difference between the L and the H phenotypes, has brought to observation also the presence of intermediate patterns between the two. Robba and co-authors 22 reported the presence of transitional phenotypes characterized by the appearance of inhomogeneously distributed atelectasis and peri-bronchial opacities. The association of these morphological aspects with the time sequence of the disease has even reawakened the debate on the correctness of the usage of term "phenotype" (as univocal external expression of a disease) in favor of the term "stage" of the disease 11 . The debate will continue but the presence in the same patient of morphological elements of different phases of inflammation, in the same time or in temporal sequence speak in favor of stating that the Covid has one phenotype constituted by different stages 23 (by definition a "full disease phenotype incorporates the abnormal phenotypes realized at each stage of the disease course") 23 . Nowadays the application of PEEP is finalized both to contribute to the maintenance of acceptable gas exchange (specifically blood oxygenation) and to position the pressure volume loop during ventilation in a range that minimizes tidal excursions (in order to reduce atelectotrauma and volu-/baro-trauma 24 ). In fact, the direct effect of PEEP is to keep a definite amount of gas inside alveoli throughout expiration, thus maintaining them open, constituting a buffer for gas exchange, avoiding cyclic opening and closing 25 . The search for the "best PEEP" has been at the center of a debate that have inflamed scientific literature over the past forty years. It is now accepted that in order to achieve the best combination between respiratory mechanics, oxygenation, hemodynamics and lung protection it is necessary to accept a compromise 26 . Therefore, the ways to titrate and to monitor the effects of PEEP are different and highly dependent on the goals that the healthcare provider wishes to pursue. In general, they can be classified in physiological and morphometric methods. Physiological methods make use of different portions of the lung pressure volume curve 27 , compliance of the respiratory system 28 , gas exchange parameters 29, 30 or transpulmonary pressure 31 . Morphometric methods are based on imaging technology as computed tomography 32 and electrical impedance tomography 33 . The idea that the lung is inherently inhomogeneous even in healthy conditions 34 has as logical consequence the fact that, instead of having only one critical opening (or closing) pressure, it presents a continuous distribution of them along the pressure/volume curve: the mechanical implication is that recruitment (and de-recruitment) phenomena must be considered distributed stochastically all over the curve 35 . For the hysteretic characteristics of the pressure volume curves, the opening pressures do not correspond to the closing pressures. This implies that the maneuvers for opening the lung, the so called "recruitment" maneuvers 36 should reach higher pressures than the ones successively maintained with PEEP. Moreover PEEP as a procedure to prevent lung collapse, should be considered an aid to an expiratory event and inefficient per se to recruit the lung thoroughly 26 . For this reason, the application of PEEP should be anticipated by a recruitment maneuver. Recruitment can be quantified as the amount of nonaerated lung tissue that becomes aerated after a recruitment maneuver and can be measured as an absolute quantity (grams, milliliters) or as incremental proportion. In fact, a key concept that progressively has funneled through different studies is that the effectiveness of PEEP application depends on the type and distribution of lung injury. If the lung presents a diffuse loss of aeration, it behaves almost as a single compartment and the risk of lung over-inflation from PEEP application is low 37 ; on the contrary if the loss of aeration is focally distributed the system becomes multi-compartmental and can exhibit opposite response to the increment of intrathoracic pressure, resulting in a significant risk of over-inflation if high PEEP levels are used 37 . These effects of PEEP on lung parenchyma are mirrored by the significant hyperinflation that focal ARDS pattern can exhibit after lung recruitment, while lungs with diffuse and patchy aeration loss respond with a significant recruitment without relevant hyperinflation 38 . Between the lines we understand that knowing the morphology of lung injury or applying a recruitment maneuver it is possible to predict the response by lung parenchyma to the application of PEEP. As with many other researchers, we believe that COVID-19 is a specific disease 39 composed of different phases that require specific treatments and aware that treating COVID-19 as a "standard" ARDS may lead to adverse outcomes. As previously discussed, the patients affected by COVID-19 might arrive to the observation of intensivists with a composite lung pattern. In our experience it is very rare that a patient with a pure L-phenotype is admitted to intensive care if not for other reasons (decompensation of another organ system). As described by Robba et al. 22 When the possibilities of executing a lung CT are limited, an alternative way to assess the potential for recruitment is the computation of recruitment to inflation (R/I) ratio 43 . Using this method, Beloncle et al. 44 studied a series of 25 patients with COVID-19 and observed 64% highly recruitable and 36% poorly recruitable. The authors concluded that the use of R/I ratio was useful in PEEP titration procedure and could help in the prevention of the harmful effect of unnecessary high PEEP. In a small series of 12 patients, Pan et al. 45 were able to assess that the 83% of their patients were poorly recruitable and that recruitability changed when modifying body position. In Gattinoni's phenotype L 8 , corresponding to Robba's phenotype 1 22 : lung compliance is nearly normal; lung CT shows subpleural ground glass patterns together with other high-perfusion areas. Mechanism of hypoxia is the altered distribution of lung perfusion. Low to moderate levels of PEEP should be applied. The rationale behind moderate PEEP levels is the possibility (to be tested case by case) to divert pulmonary blood flow from impaired to non-damaged lung areas. If high PEEP is used in this phase, the recruiting effect will be minimal and the impairment of hemodynamics will be substantial, requiring additional fluid and vasopressors. In Robba's transitional phenotype 2, atelectasis appears and it is inhomogenously distributed. 22 The authors advocate the use of moderate to high PEEP in relation to the likely higher potential for recruitment in comparison to phenotype L/1. Of potential help is the measure of the potential for recruitment by computing the R/I ratio or by the method that is more suitable in the single units In Gattinoni's phenotype H 8 , corresponding to Robba's phenotype 3, in this condition, the strategies developed for the management ARDS should be used: protective ventilation using low tidal volumes and choice of PEEP according to accepted international guidelines 22 , 46 . In the late COVID phase H/3, when a fibrotic pattern is established, the response to recruitment and to PEEP are thought to be lower than at the beginning of the course of the disease. In summary COVID-19 is a new disease with different phases that can be catastrophic for subpopulations of patients with cardiovascular and pulmonary disease states at baseline. Appreciation for these different phases and treatment modalities including manipulation of ventilatory settings and therapeutics has made if a less lethal disease than when it emerged earlier this year. Different aspects of the disease are still largely unknown. However, laboratory investigation and clinical course of the COVID-19 show that this new disease is not a typical ARDS process, especially during the first phase. For this reason, the best strategy to be applied is to treat differently the single phases and to support the single functions of the failing organs as they appear. Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Dr. Kaye serves on the Speakers Bureau for Merck, Inc. -COVID-19 is a new disease with different phases that can be catastrophic for subpopulations of patients with cardiovascular and pulmonary disease states at baseline. -Appreciation for these different phases and treatment modalities including manipulation of ventilatory settings and therapeutics has made if a less lethal disease than when it emerged earlier this year. -Laboratory investigation and clinical course of the COVID-19 show that this new disease is not a typical ARDS process, especially during the first phase, thus more thorough investigations and studies are needed -Further studies are needed to assess what is the best strategy to be applied to treat the single phases and to support the single functions of the failing organs as they appear Clinical features of patients infected with 2019 novel coronavirus in Wuhan Timeline of WHO's response to COVID-19 World Health Organization(WHO) A contemporary review on pathogenesis and immunity of COVID 19 infection Identifying phenotypes of COVID-19, defining their pathogenesis, and targeting treatments could improve outcomes COVID 19: a clue from innate immunity A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression COVID-19 pneumonia: different respiratory treatments for different phenotypes? Covid-19 Does Not Lead to a 'Typical' Acute Respiratory Distress Syndrome Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target Stages or phenotypes? A critical look at COVID-19 pathophysiology The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients Mechanical ventilation to minimize progression of lung injury in acute respiratory failure Ventilator-Induced Lung Injury The concept of 'baby lung Comment Identification of pathophysiological patterns for triage and respiratory support in COVID-19 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 Toward an ontological treatment of disease and diagnosis the Contribution of Biophysical Lung Injury To the Development of Biotrauma Positive end-expiratory pressure Selecting the 'right' positive end-expiratory pressure level The effect of the pressure-volume curve for positive end-expiratory pressure titration on clinical outcomes in acute respiratory distress syndrome: A systematic review Use of dynamic compliance for open lung positive end-expiratory pressure titration in an experimental study A comparison of methods to identify open-lung PEEP A decremental PEEP trial identifies the PEEP level that maintains oxygenation after lung recruitment Mechanical Ventilation Guided by Esophageal Pressure in Acute Lung Injury Anatomical and functional intrapulmonary shunt in acute respiratory distress syndrome* Bedside estimation of recruitable alveolar collapse and hyperdistension by electrical impedance tomography Lung regional stress and strain as a function of posture and ventilatory mode Recruitment and Derecruitment during Acute Respiratory Failure Lung recruitment in acute respiratory distress syndrome Mechanical Ventilation in Patients with Acute Respiratory Distress Syndrome Lung morphology predicts response to recruitment maneuver in patients with acute respiratory distress syndrome PEEP levels in COVID-19 pneumonia Advanced respiratory monitoring in COVID-19 patients: use less High versus low PEEP in non-recruitable collapsed lung tissue: possible implications for patients with COVID-19 Potential for lung recruitment estimated by the recruitment-to-inflation ratio in acute respiratory distress syndrome a clinical trial Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome Lung Recruitability in SARS-CoV-2 Associated Acute Respiratory Distress Syndrome: A Single-center